Loading clinical trials...
Loading clinical trials...
Cutaneous melanomas represent 4 to 11% of cutaneous cancers, but is responsible for 75% of the deaths reported for these pathologies. The incidence rate double every 10 years. Fourteen thousand cases ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Centre Hospitalier Universitaire de Nice
NCT05039801 · Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, and more
NCT06391099 · Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma, and more
NCT06673095 · Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8
NCT06999980 · Cutaneous Melanoma, Mucosal Melanoma
NCT07230613 · Cutaneous Melanoma, Stage III, Mucosal Melanoma
CHU de Nice
Nice
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions